Table 3.

Rate of CVC utilization rate, CLABSI incidence and mortality

Year	2014	2015	2016	2017	2018	P value for trend test
No. of hospitalization days	271,383	231,437	215,747	205,648	164,707
No. of device days	120,595	100,367	93,466	86,141	66,016
No. of patients with CLABSI	159	119	151	164	109
No. of death with CLABSI	32	31	27	27	10
Utilization rate of CVCs, % M (Q1, Q2, Q3)	44.44 (32.46, 44.28, 58.27)	43.37 (31.42, 45.86, 61.45)	43.32 (32.13, 44.71, 60.57)	41.89 (30.06, 39.47, 53.82)	40.08 (21.29, 35.68, 45.46)	.000
CLABSI rate, per 1000 catheter-days M (Q1, Q2, Q3)	1.32 (.00, .87, 1.75)	1.19 (.00, .34, 1.62)	1.62 (.00, .97, 1.67)	1.9 (.39, 1.24, 1.89)	1.65 (.00, 1.00, 1.77)	.000
Mortality, % M (Q1, Q2, Q3)	20.13 (.00, 12.12, 33.33)	26.05 (.00, 10.00, 33.33)	17.88 (.00, 16.67, 33.33)	16.46 (.00, .00, 33.33)	9.17 (.00, .00, 22.22)	0.024

Mortality: average mortality rate of CLABSI patients in intensive-care units

P values: < 0.05 were considered statistically significant